Cipher Pharmaceuticals (OTCPK:CPHRF) announces that its New Drug Submission for FDA approved A-101 40% topical solution for the treatment of raised seborrheic keratoses ("SKs") has been accepted for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results